With every passing day, new discoveries are made that lend support to the increasing and important role biomarker analysis and tumor profiling play in personalized cancer care. Caris Life Sciences® is actively participating in research to advance the understanding of molecular science, further enabling the delivery of precision medicine.

View Posters & Abstracts for:
Caris Molecular Intelligence®  | ADAPT Biotargeting System™

View Caris Manuscripts on PubMed:

2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

  • Caris will deliver 10 poster presentations at the 2016 American Association for Cancer Research (AACR) Annual Meeting from April 16-20, in New Orleans, La., including one late-breaking poster presentation. See what others said about AACR this year on Twitter.

    Adaptive dynamic artificial poly-ligand targeting (ADAPT) enables plasma-based exosome profiling with potential diagnostic utility (Late-Breaker)

    Multiplatform molecular profiling of invasive lobular breast cancer

    Analysis of MET-amplified solid tumors using chromogenic in situ hybridization (CISH)

    Molecular and genomic characterization of SCLC

    Clinico-pathological and molecular features associated with TP53 mutation in 3457 molecularly-profiled colorectal cancers (CRCs)

    Frequent BRCA2 somatic mutations in colorectal cancer patients with mircrosatellite instability (MSI)

    Mutations on the homologous recombination pathway in 13 cancer types

    Caveolin-1: Beyond a marker for basal-like breast cancers

    Expression of class III beta-tubulin (TUBB3) in 3580 colorectal cancers (CRCs) and correlation with clinico-pathological and molecular features

    A rationale for treatment of colorectal cancer with mitomycin C and crizotinib

    Read More

  • Uterine leiomyosarcomas exhibit distinct drug resistance molecular profiles compared to extrauterine leiomyosarcomas-A comprehensive analysis of 1023 leiomyosarcomas

    Vulvar and vaginal melanoma-A distinct subclass of melanoma based on a comprehensive molecular analysis of 51 cases

    Identification of Molecular Targets in Vulvar Cancers

    Unique Molecular Signatures Between High-Grade and Low-Grade Endometrial Stromal Sarcoma-An Analysis of 96 Cases

    Profiling of Triple Negative Endometrial Cancers (TNEC) and Triple Negative Breast Cancers (TNBC) Reveals Unique Expression Profiles

    Molecular Profiling Reveals Distinct Molecular Landscapes in 545 Cases of Triple Negative Endometrial Cancer

    Multiplatform tumor-profiling of 50 malignant Sertoli-Leydig cell tumors of the ovary reveals therapeutic

    Read More

  • Impact of molecular profiling on overall survival of patients with advanced ovarian cancer

    Read More

  • Tumor profiling of 431 pancreatic tumors from elderly patients

    PD-1/PD-L1 expression and molecular associations in HPB malignancies

    Molecular characterization of colorectal tumors in young patients compared with older patients and impact on outcome

    Molecular profiling of appendix-derived pseudomyxoma peritonei (PMP)

    Examination of Topoisomerase I (TOPO1) Expression in Metastatic GI Cancers

    Read More

  • Taxane sensitivity markers in prostate cancer

    Frequency of BRCA mutations and co-occurring alterations in prostate cancer

    Molecular profiling of non-urothelial bladder cancer: adenocarcinoma and squamous cell carcinoma

    Comprehensive profiling of renal medullary and collecting duct carcinomas

    Read More